Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Submission Process and Features - Introductory Video Series
-
If you have not yet seen them, check out our 4 part video series on Upcoming Submission Process and Features
The videos act as bite sized summaries of the changes coming to the PAAB submission process with the introduction of the Accelerated Review Options (ARO).
Video 1: What is ARO?
Video 2: What's new?
Video 3: Submission Fees
Video 4: Other ResourcesLet us know what you think below.
